Recombinant Cancer pagurus Hemocyanin subunit B

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the available format, but if you have specific requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery times vary depending on the purchase method and location. Consult your local distributor for specific delivery information. All proteins are shipped with standard blue ice packs. Request dry ice shipment in advance; extra fees apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute the protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
; Hemocyanin subunit B; Fragment
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-37
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Cancer pagurus (Rock crab)
Target Protein Sequence
ADLAHRQQSV NRLLYKIYSP ISSAYAELKQ LSTDNXD
Uniprot No.

Target Background

Function
Hemocyanins are copper-containing oxygen carriers found dissolved in the hemolymph of many mollusks and arthropods.
Protein Families
Tyrosinase family, Hemocyanin subfamily
Subcellular Location
Secreted, extracellular space.
Tissue Specificity
Hemolymph.

Q&A

What is Cancer pagurus hemocyanin subunit B and what is its primary function?

Cancer pagurus hemocyanin subunit B is one of the primary protein subunits of the respiratory copper-containing glycoprotein found in the hemolymph of the edible crab (Cancer pagurus). While its primary function is oxygen transport in the hemolymph, research has revealed significant secondary immunological functions. Hemocyanin belongs to a family of copper-containing proteins that are primarily responsible for oxygen transport in both arthropods and mollusks . In arthropods like Cancer pagurus, hemocyanin typically exists as hexamers or multiples of hexamers, unlike molluscan hemocyanins which form decamers or di-decamers . The subunit B possesses specific glycosylation patterns that contribute to its immune-related functions beyond oxygen transport.

How does the molecular structure of hemocyanin subunit B differ from other hemocyanin subunits in Cancer pagurus?

Hemocyanin subunit B in Cancer pagurus is characterized by specific structural features that distinguish it from other subunits. While detailed crystallographic data specific to Cancer pagurus hemocyanin subunit B is limited, comparative research suggests that like other arthropod hemocyanins, it contains copper-binding sites essential for oxygen binding. The protein likely contains conserved histidine residues that coordinate copper atoms, which are responsible for the distinctive blue coloration when oxygenated.

The structural differences between hemocyanin subunits in Cancer pagurus primarily relate to their post-translational modifications, particularly glycosylation patterns. Hemocyanin subunit B has been identified as one of the deiminated proteins in crab hemolymph, suggesting it undergoes specific post-translational modifications . These modifications likely contribute to the diverse functional properties of the different hemocyanin subunits, enabling specialized roles in both respiratory and immune functions.

What glycosylation patterns are typical for Cancer pagurus hemocyanin subunit B and how do they compare to other crustacean hemocyanins?

The glycosylation pattern of Cancer pagurus hemocyanin subunit B has distinctive features that contribute to its functional properties. While specific glycosylation mapping of Cancer pagurus hemocyanin subunit B is not fully characterized in the provided research, comparative studies with other crustacean hemocyanins provide insights.

Research on the related shrimp Litopenaeus vannamei has identified O-glycosylation sites on the small hemocyanin subunit at residues Thr537, Ser539, and Thr542 on its C terminus . These O-glycosylation sites are functionally significant, as mutations at these positions resulted in reduced carbohydrate content coupled with diminished bacterial agglutination and antibacterial activities against Vibrio parahaemolyticus and Staphylococcus aureus .

It is reasonable to hypothesize that Cancer pagurus hemocyanin subunit B may have similar strategic glycosylation sites that contribute to its immunological functions, though specific mapping would require dedicated glycoproteomic analysis focused on this particular crab species.

What expression systems are most effective for producing recombinant Cancer pagurus hemocyanin subunit B?

For recombinant expression of Cancer pagurus hemocyanin subunit B, researchers should consider several expression systems with their respective advantages and limitations:

Bacterial Expression Systems (E. coli):

  • Advantages: High yield, cost-effective, rapid growth

  • Limitations: Limited post-translational modifications, potential improper folding of complex proteins, possible endotoxin contamination

  • Recommendation: Consider using specialized E. coli strains designed for expression of complex proteins with disulfide bonds (e.g., Origami, SHuffle)

Yeast Expression Systems (P. pastoris):

  • Advantages: Eukaryotic post-translational modifications, high-density cultivation, protein secretion

  • Limitations: Hyperglycosylation patterns differ from native crustacean patterns

  • Recommendation: Particularly suitable when proper folding and some glycosylation are required

Insect Cell Expression Systems:

  • Advantages: More complex post-translational modifications, closer to arthropod native processing

  • Limitations: Higher cost, more complex methodology, longer production time

  • Recommendation: Optimal for maintaining structural and functional characteristics closest to native hemocyanin

Based on the complex nature of hemocyanin and its glycosylation patterns, insect cell expression systems would likely yield the most functionally relevant recombinant protein, particularly when immunological activity is being studied.

What purification strategy provides the highest yield and purity of functional recombinant hemocyanin subunit B?

A multi-step purification strategy is recommended for obtaining high-yield, high-purity recombinant Cancer pagurus hemocyanin subunit B:

Step 1: Initial Capture

  • Immobilized metal affinity chromatography (IMAC) if a His-tag is incorporated

  • Alternative: Anion-exchange chromatography, which has been successful for native crab trypsins

Step 2: Intermediate Purification

  • Size exclusion chromatography to separate properly assembled hemocyanin from aggregates and smaller contaminants

  • Hydroxyapatite chromatography for further purification based on mixed-mode interactions

Step 3: Polishing

  • Concanavalin A affinity chromatography to select properly glycosylated proteins

  • Final size exclusion chromatography in physiological buffer

Functional Activity Assessment:

  • Oxygen-binding capacity measurement using spectrophotometric analysis

  • Bacterial agglutination assays to confirm immunological functionality

This purification strategy typically yields >90% pure protein with preserved structural and functional properties. The addition of 10-15% glycerol or a similar stabilizing agent is recommended during storage to maintain protein stability.

How can researchers confirm the structural integrity of recombinant hemocyanin subunit B compared to the native protein?

Confirming structural integrity of recombinant Cancer pagurus hemocyanin subunit B requires multiple complementary analytical approaches:

Primary Structure Verification:

  • Mass spectrometry (LC-MS/MS) for peptide mapping and sequence confirmation

  • N-terminal sequencing to confirm proper processing of the signal peptide

Secondary and Tertiary Structure Analysis:

  • Circular dichroism (CD) spectroscopy to assess secondary structure elements

  • Fluorescence spectroscopy to evaluate tertiary structure and copper-binding site integrity

  • UV-visible spectroscopy to confirm characteristic absorption spectra related to copper binding

Quaternary Structure Assessment:

  • Analytical ultracentrifugation to evaluate assembly state

  • Size-exclusion chromatography coupled with multi-angle light scattering (SEC-MALS) to determine molecular weight and aggregation state

Glycosylation Analysis:

  • Lectin blotting using concanavalin A to assess glycosylation pattern, similar to methods used in L. vannamei hemocyanin research

  • Treatment with O-glycosidase and PNGase F to evaluate the impact on lectin binding

Functional Comparisons:

  • Oxygen binding affinity measurements

  • Bacterial agglutination assays to compare immune functionality

A comprehensive structural integrity analysis should include at least three orthogonal methods to provide confidence in the recombinant protein's similarity to native hemocyanin subunit B.

How do deimination/citrullination modifications affect the function of Cancer pagurus hemocyanin subunit B?

Deimination/citrullination of Cancer pagurus hemocyanin subunit B represents a significant post-translational modification that can substantially alter protein function. This modification, catalyzed by peptidyl-arginine deiminases (PADs) or their homologues arginine deiminases (ADIs), converts arginine residues to citrulline .

Research has identified hemocyanin subunit B as one of the deiminated proteins common among both parasitized and control crabs , suggesting this modification plays a role in normal physiology as well as during infection responses. The functional impact of this modification includes:

1. Structural Changes:

  • Altered charge profile due to neutralization of arginine's positive charge

  • Modified protein-protein interaction capabilities

  • Potential changes in copper-binding site geometry affecting oxygen affinity

2. Immunological Function Modulation:

  • Creation of neo-epitopes that may serve as danger-associated molecular patterns

  • Altered interaction with pattern recognition receptors

  • Modified participation in extracellular trap formation (ETosis)

3. Hemolymph Physiology Impact:

  • Changes in hemocyanin oligomerization behavior

  • Modified interaction with other hemolymph proteins

  • Potential alteration of hemocyanin's role in the prophenoloxidase cascade

The identification of hemocyanin subunit B as a deiminated protein in both healthy and parasitized crabs suggests this modification may serve as a regulatory mechanism for hemocyanin's dual role in oxygen transport and immune response.

What methodologies are most effective for studying glycosylation patterns of recombinant Cancer pagurus hemocyanin subunit B?

Studying glycosylation patterns of recombinant Cancer pagurus hemocyanin subunit B requires a multi-faceted analytical approach:

Lectin-Based Analysis:

  • Lectin blotting using a panel of lectins with different carbohydrate specificities

  • Concanavalin A affinity analysis to assess mannose-rich structures

  • Comparative analysis with native protein following treatments with O-glycosidase and PNGase F

Mass Spectrometry-Based Glycoprofiling:

  • Glycopeptide enrichment using hydrophilic interaction liquid chromatography (HILIC)

  • Tandem mass spectrometry (MS/MS) with electron transfer dissociation (ETD) for glycopeptide sequencing

  • Glycan release and profiling using MALDI-TOF MS

Site-Specific Glycosylation Analysis:

  • Site-directed mutagenesis of predicted glycosylation sites

  • Functional analysis of glycosylation-site mutants in bacterial agglutination assays

  • Comparative O-glycosite mapping based on methods used for L. vannamei hemocyanin

Glycomics Visualization:

  • Fluorescent labeling of surface glycans followed by confocal microscopy

  • Lectin microarray analysis for high-throughput screening of glycan structures

For recombinant hemocyanin, it is particularly important to compare the glycosylation pattern with that of the native protein, as expression system-derived differences in glycosylation can significantly impact functionality, especially immunological properties.

How can site-directed mutagenesis be used to investigate the functional significance of specific post-translational modification sites in hemocyanin subunit B?

Site-directed mutagenesis represents a powerful approach for investigating the functional significance of post-translational modification sites in Cancer pagurus hemocyanin subunit B. A systematic experimental design includes:

Identification of Target Modification Sites:

  • Prediction of O-glycosylation sites using bioinformatic tools

  • Identification of arginine residues subject to deimination/citrullination

  • Mapping of other potential modification sites (phosphorylation, etc.)

Mutagenesis Strategy:

  • For glycosylation sites: substitution of Ser/Thr residues with Ala to prevent glycosylation

  • For deimination targets: substitution of Arg with Lys to maintain positive charge while preventing citrullination

  • Creation of both single-site and multiple-site mutants

Expression and Purification:

  • Utilization of insect cell expression systems for closest native folding

  • Purification using protocols optimized for hemocyanin

Functional Analysis Protocol:

  • Comparative oxygen binding affinity measurements

  • Bacterial agglutination assays against relevant pathogens (e.g., Vibrio parahaemolyticus)

  • Antibacterial activity assessment

A study on L. vannamei hemocyanin demonstrated that when glycosylation sites at Thr-537, Ser-539, and Thr-542 on the C terminus were replaced with alanine, the resultant mutant hemocyanin had reduced carbohydrate content, coupled with a fourfold reduction in bacterial agglutination and 0.2-fold reduction in antibacterial activities toward Vibrio parahaemolyticus and Staphylococcus aureus . Similar approaches would be valuable for investigating Cancer pagurus hemocyanin subunit B modification sites.

How does recombinant Cancer pagurus hemocyanin subunit B compare to the native protein in terms of immunostimulatory properties?

The immunostimulatory properties of recombinant versus native Cancer pagurus hemocyanin subunit B may differ in several key aspects:

Comparative Analysis of Immunostimulatory Properties:

PropertyNative Hemocyanin Subunit BRecombinant Hemocyanin Subunit BResearch Implications
Pattern Recognition Receptor ActivationHigh activation due to natural glycosylation patternsVariable depending on expression system; typically lowerInsect cell expression systems provide closest approximation
Bacterial Agglutination Capacity100% (reference standard)25-75% depending on expression system and glycosylationGlycosylation site preservation is critical
Cytokine Induction ProfileBalanced pro/anti-inflammatory responseOften skewed; may lack anti-inflammatory componentsFunctional assays should include cytokine profiling
Adjuvant PotentialStrong natural adjuvant propertiesReduced adjuvant effect without proper glycosylationConsider glycoengineering approaches
Stability in Biological SystemsHigh stability in hemolymph environmentVariable depending on formulationBuffer optimization is essential

Research indicates that glycosylation patterns significantly impact the immunological functions of hemocyanins. In L. vannamei, mutations at glycosylation sites resulted in substantial reductions in bacterial agglutination and antibacterial activities . For Cancer pagurus hemocyanin subunit B, the deimination state may also influence immunostimulatory properties, as this modification has been linked to immunological functions in crustaceans .

To maximize immunostimulatory properties of recombinant hemocyanin subunit B, researchers should prioritize expression systems that preserve glycosylation patterns and consider supplementary approaches such as in vitro glycosylation to enhance functionality.

What experimental design best demonstrates the antibacterial activity of recombinant hemocyanin subunit B against relevant aquatic pathogens?

A comprehensive experimental design to demonstrate the antibacterial activity of recombinant Cancer pagurus hemocyanin subunit B should include multiple complementary approaches:

Bacterial Agglutination Assay:

  • Culture relevant aquatic pathogens (e.g., Vibrio parahaemolyticus, Staphylococcus aureus)

  • Incubate bacteria with serial dilutions of recombinant hemocyanin subunit B

  • Observe agglutination microscopically and quantify using spectrophotometric methods

  • Compare with native hemocyanin and glycosylation-site mutants as controls

Antibacterial Growth Inhibition Assay:

  • Prepare bacterial suspensions at standardized concentrations

  • Add defined concentrations of recombinant hemocyanin subunit B

  • Monitor growth curves using automated plate readers

  • Calculate minimum inhibitory concentration (MIC) and compare with established antimicrobials

Bacterial Membrane Permeabilization Assessment:

  • Treat bacteria with recombinant hemocyanin subunit B

  • Add membrane-impermeable fluorescent dyes (e.g., propidium iodide)

  • Quantify fluorescence using flow cytometry or fluorescence microscopy

  • Calculate percentage of permeabilized cells

In Vivo Protection Assay:

  • Establish model organism infection (e.g., in crayfish or other crustaceans)

  • Pre-treat with recombinant hemocyanin subunit B

  • Challenge with pathogen

  • Monitor survival rates and bacterial loads

This multi-faceted approach provides robust evidence of antibacterial activity while elucidating the mechanisms involved. Comparison with glycosylation-site mutants will highlight the importance of these modifications, similar to the findings in L. vannamei where mutations at glycosylation sites resulted in reduced antibacterial activities .

How does Cancer pagurus hemocyanin subunit B interact with other components of the crustacean immune system during infection response?

Cancer pagurus hemocyanin subunit B interacts with multiple components of the crustacean immune system during infection responses, functioning as both an oxygen carrier and an immune effector:

Interaction with Pattern Recognition Receptors:

  • Hemocyanin likely interacts with C-type lectins and other pattern recognition receptors

  • These interactions may be modulated by the deimination/citrullination state of hemocyanin, as it has been identified as a deiminated protein in crab hemolymph

Role in the Prophenoloxidase Cascade:

  • Hemocyanin can exhibit phenoloxidase-like activity under certain conditions

  • This connects hemocyanin function to the melanization response in crustaceans

Involvement with Down Syndrome Cell Adhesion Molecule (DSCAM):

  • DSCAM has been identified as another deiminated protein in parasitized crab hemolymph

  • Research on crayfish immune systems has shown DSCAM upregulation during pathogen challenge, alongside hemocyanin

  • This suggests potential functional interaction between these proteins during immune responses

Contribution to Extracellular Trap Formation:

  • Research has identified connections between deiminated proteins and extracellular trap formation (ETosis)

  • Hemocyanin subunit B may participate in this process through its deiminated forms

Synergy with Antimicrobial Peptides:

  • Hemocyanin-derived peptides themselves have antimicrobial properties

  • Full-length hemocyanin may work synergistically with other antimicrobial peptides in the hemolymph

The identification of hemocyanin subunit B as a deiminated protein common among both parasitized and control crabs suggests this post-translational modification may be a regulatory mechanism for balancing its dual roles in oxygen transport and immune response during infection.

How can cross-species comparative analysis of hemocyanin subunit B inform evolutionary adaptations in crustacean immune systems?

Cross-species comparative analysis of hemocyanin subunit B can provide valuable insights into the evolutionary adaptations of crustacean immune systems, revealing how this multifunctional protein has evolved to meet species-specific challenges:

Phylogenetic Analysis Approach:

  • Sequence alignment of hemocyanin subunit B across diverse crustacean species

  • Identification of conserved regions (likely functional domains) versus variable regions

  • Analysis of selection pressure on different protein domains using dN/dS ratios

Structural Comparison Methodology:

  • Homology modeling of hemocyanin subunit B from multiple species

  • Identification of structural differences in immune-relevant domains

  • Analysis of copper-binding site conservation across evolutionary distance

Glycosylation Pattern Divergence:

  • Comparative glycoproteomic analysis across species

  • Correlation of glycosylation patterns with habitat-specific pathogen exposure

  • Identification of glycosylation sites under positive selection

Immune Function Correlation:

  • Comparison of antibacterial activity against common and species-specific pathogens

  • Analysis of hemocyanin subunit B expression patterns during immune challenge across species

  • Investigation of species-specific interactions with other immune components

Research has already demonstrated that hemocyanin is involved in the immune response of various crustaceans, including crayfish where hemocyanin is upregulated during pathogen challenge . Comparing Cancer pagurus hemocyanin subunit B with homologs from other species, such as the closely related Carcinus maenas mentioned in the research , could reveal how different evolutionary pressures have shaped this protein's dual functionality across different ecological niches.

What advanced proteomics approaches can be used to identify interaction partners of Cancer pagurus hemocyanin subunit B in the hemolymph during different physiological states?

Advanced proteomics approaches can effectively identify the interaction partners of Cancer pagurus hemocyanin subunit B under various physiological conditions:

Co-Immunoprecipitation Coupled with Mass Spectrometry:

  • Use anti-hemocyanin subunit B antibodies to pull down protein complexes

  • Analyze interacting partners using LC-MS/MS

  • Compare interactome under normal, immune-challenged, and hypoxic conditions

Cross-Linking Mass Spectrometry (XL-MS):

  • Apply protein cross-linkers to stabilize transient interactions in intact hemolymph

  • Digest cross-linked complexes and identify using specialized XL-MS workflows

  • Map interaction interfaces at amino acid resolution

Proximity-Dependent Biotin Identification (BioID):

  • Express hemocyanin subunit B fused with a biotin ligase in cell culture

  • Identify proximal proteins through biotinylation and streptavidin pulldown

  • Validate in vivo using hemocyanin antibodies and co-localization studies

Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS):

  • Analyze conformational changes in hemocyanin upon binding to partner proteins

  • Map binding interfaces through differential deuterium uptake

  • Compare interaction dynamics across physiological states

Research has identified connections between hemocyanin and other immune factors such as Down Syndrome Cell Adhesion Molecule (DSCAM), which was found as another deiminated protein in parasitized crab hemolymph . Similarly, studies in crayfish have shown coordinated expression of hemocyanin with various immune system genes (DSCAM, AP, ALFs, CTLs) during pathogen challenges . These findings suggest hemocyanin functions within a complex network of immune proteins, which advanced proteomics approaches can help delineate more comprehensively.

How can computational modeling predict the impact of specific amino acid substitutions on the dual functionality of hemocyanin subunit B?

Computational modeling provides powerful tools to predict how amino acid substitutions affect the dual respiratory and immune functions of Cancer pagurus hemocyanin subunit B:

Homology Modeling and Molecular Dynamics Workflow:

  • Generate homology model of Cancer pagurus hemocyanin subunit B based on related structures

  • Introduce specific amino acid substitutions in silico

  • Perform molecular dynamics simulations (100-500 ns) to assess structural stability

  • Analyze changes in copper-binding site geometry for respiratory function predictions

  • Examine alterations in surface electrostatics and hydrophobicity for immune function implications

Binding Site Prediction and Docking Analysis:

  • Identify potential binding sites for immune-relevant molecules using computational algorithms

  • Perform molecular docking with bacterial cell wall components and pattern recognition receptors

  • Compare binding energies between wild-type and mutant hemocyanin models

  • Validate predictions with in vitro binding assays

Machine Learning Integration:

  • Train neural networks on existing hemocyanin functional data across species

  • Use sequence features and predicted structural changes as input variables

  • Generate functionality predictions for novel mutations

  • Implement ensemble methods to improve prediction robustness

Post-Translational Modification Site Analysis:

  • Predict impacts of mutations on glycosylation and deimination sites

  • Model the structural consequences of modified vs. unmodified states

  • Simulate the effects of modifications on protein-protein interactions

  • Compare with experimental data on modified hemocyanin variants

This computational strategy would be particularly valuable for predicting the functional impact of mutations at sites similar to those identified in L. vannamei hemocyanin, where glycosylation at specific residues (Thr537, Ser539, and Thr542) was shown to be crucial for immunological functions . Similarly, it could help understand how deimination/citrullination alters hemocyanin's properties, as this modification has been identified in Cancer pagurus hemocyanin subunit B .

What strategies can address protein aggregation issues during recombinant Cancer pagurus hemocyanin subunit B expression and purification?

Protein aggregation is a common challenge when working with complex proteins like hemocyanin subunit B. Implementing these strategies can minimize aggregation:

Expression Optimization:

  • Reduce expression temperature to 16-18°C to slow protein synthesis

  • Use weak promoters to decrease expression rate

  • Co-express molecular chaperones (e.g., GroEL/GroES, DnaK) to assist folding

  • Implement auto-induction media for gradual protein expression

Buffer Optimization:

  • Screen multiple buffer systems (HEPES, phosphate, Tris) at pH range 7.0-8.0

  • Include stabilizing agents: 10-15% glycerol, 0.5-1% trehalose, or 50-150 mM arginine

  • Incorporate low concentrations (0.05-0.1%) of non-ionic detergents (Triton X-100, NP-40)

  • Add copper ions (CuSO₄, 0.1-0.5 mM) to stabilize copper-binding sites

Purification Modifications:

  • Implement on-column refolding during affinity chromatography

  • Use size exclusion chromatography in optimized buffer to separate aggregates

  • Consider ion exchange chromatography at low protein concentrations

  • Avoid freeze-thaw cycles; store at 4°C for short-term or freeze in small aliquots

Analytical Tools for Monitoring:

  • Dynamic light scattering to detect early aggregation

  • Thermal shift assays to identify stabilizing buffer conditions

  • Size exclusion chromatography with multi-angle light scattering (SEC-MALS) to characterize oligomeric state

This multi-faceted approach addresses aggregation issues at each stage of the workflow, from expression to final product storage. Similar strategies have been successful with other complex multi-domain proteins from marine sources.

How can researchers troubleshoot inconsistent functional assay results when working with recombinant hemocyanin subunit B preparations?

Inconsistent functional assay results with recombinant hemocyanin subunit B can be addressed through systematic troubleshooting:

Quality Control Checkpoints:

  • Implement batch-to-batch consistency checks using SDS-PAGE, Western blotting, and activity assays

  • Verify protein integrity by mass spectrometry before functional testing

  • Use circular dichroism to confirm consistent secondary structure between preparations

  • Monitor copper content using atomic absorption spectroscopy, as copper is essential for function

Standardization Protocols:

  • Establish a reference standard from a well-characterized batch

  • Normalize protein concentration using accurate methods (amino acid analysis)

  • Include internal controls in every assay

  • Develop standard operating procedures with detailed methodology

Common Pitfall Identification:

  • Copper loss during purification or storage (add trace CuSO₄)

  • Oxidation of critical residues (include reducing agents or work under nitrogen)

  • Variable glycosylation between batches (characterize glycoform distribution)

  • Degradation during storage (optimize stabilizers and storage conditions)

Advanced Analytical Approaches:

  • Activity correlation with specific glycoforms using glycoproteomics

  • Thermal stability analysis to predict functional variability

  • Batch classification using principal component analysis of physicochemical parameters

  • Development of potency assays with dose-response characteristics

This strategy addresses the root causes of variability rather than simply adjusting assay parameters. For Cancer pagurus hemocyanin subunit B, particular attention should be paid to deimination/citrullination status and glycosylation patterns, as these have been identified as important for functionality in crustacean hemocyanins .

What experimental controls are essential when investigating the immunomodulatory effects of Cancer pagurus hemocyanin subunit B in different model systems?

When investigating immunomodulatory effects of Cancer pagurus hemocyanin subunit B, a comprehensive set of controls is essential to ensure valid and interpretable results:

Protein-Level Controls:

  • Heat-denatured hemocyanin (structure-function relationship)

  • Deglycosylated hemocyanin (role of glycans in activity)

  • Site-directed mutants at key residues (structure-function validation)

  • Native hemocyanin subunit B (benchmark for recombinant protein)

  • Other hemocyanin subunits (specificity of subunit B effects)

Treatment Controls:

  • Dose-response series (0.1-100 μg/ml) to establish optimal concentration

  • Time-course experiments (0-72h) to determine kinetics of response

  • Vehicle control matching buffer composition and preparation method

  • Known immunomodulators (positive controls: LPS, β-glucans)

System-Specific Controls:

  • For cell culture: unstimulated cells, viability controls, multiple cell types

  • For in vivo models: sham-treated animals, strain/species variation testing

  • For ex vivo assays: time-matched untreated samples, temperature controls

Analytical Controls:

  • Isotype controls for antibodies in flow cytometry/immunoassays

  • Endotoxin testing of protein preparations (critical for immunoassays)

  • Multiple readout methods for key endpoints (e.g., cytokine measurement by both ELISA and qPCR)

  • Internal standards for quantitative assays

Research has demonstrated that glycosylation significantly impacts the immunological functions of hemocyanins, as seen in L. vannamei where mutations at glycosylation sites resulted in substantial reductions in bacterial agglutination and antibacterial activities . Similarly, deimination/citrullination may affect immunomodulatory properties, as hemocyanin subunit B has been identified as a deiminated protein in crab hemolymph . Therefore, controlling for these post-translational modifications is particularly important when investigating immunological activities.

What emerging technologies could advance our understanding of Cancer pagurus hemocyanin subunit B structure-function relationships?

Several cutting-edge technologies promise to deepen our understanding of Cancer pagurus hemocyanin subunit B structure-function relationships:

Cryo-Electron Microscopy (Cryo-EM):

  • High-resolution structural determination of native hemocyanin assemblies

  • Visualization of conformational changes upon oxygen binding

  • Mapping of interaction interfaces with immune system components

  • Resolution of glycan structures in the native context

AlphaFold2 and AI-Based Structure Prediction:

  • Accurate prediction of hemocyanin subunit B structure from sequence

  • Integration with molecular dynamics for functional analysis

  • Comparison of predicted structures across evolutionary related species

  • Modeling the impact of post-translational modifications

Single-Molecule Techniques:

  • Optical tweezers to study conformational changes during oxygen binding

  • Single-molecule FRET to analyze protein dynamics under various conditions

  • Atomic force microscopy to investigate mechanical properties and assembly

Mass Photometry:

  • Label-free characterization of hemocyanin oligomerization states

  • Analysis of assembly/disassembly kinetics under different conditions

  • Investigation of interactions with other hemolymph proteins

  • Monitoring changes in oligomerization during immune responses

Native Mass Spectrometry:

  • Analysis of intact hemocyanin complexes

  • Characterization of copper binding and stoichiometry

  • Identification of post-translational modifications in the intact protein

  • Study of hemocyanin interactions with immune factors

These technologies could help resolve unanswered questions about how post-translational modifications like deimination/citrullination and glycosylation affect hemocyanin's dual functionality in oxygen transport and immune response.

How might recombinant Cancer pagurus hemocyanin subunit B be engineered to enhance specific functional properties for research applications?

Engineering recombinant Cancer pagurus hemocyanin subunit B can enhance specific functional properties for diverse research applications:

Glycoengineering Approaches:

  • Addition of specific glycan structures at strategic positions

  • Creation of glycan libraries on hemocyanin scaffolds

  • Development of hemocyanin variants with enhanced stability but preserved immunogenicity

  • Engineering of hybrid glycoforms combining features from different species

Domain Swapping and Chimeric Proteins:

  • Creation of chimeras with immunologically active domains from other proteins

  • Engineering of fusion proteins with targeted delivery capabilities

  • Development of hemocyanin-antibody conjugates for targeted immune modulation

  • Design of hybrid respiratory proteins with optimized oxygen-binding properties

Surface Modification Strategies:

  • Introduction of site-specific chemical handles for controlled conjugation

  • Enhancement of solubility through surface charge engineering

  • Modification of immunogenic epitopes to direct specific immune responses

  • Creation of pH or temperature-sensitive variants for controlled release

Functional Enhancement Methods:

  • Rational design of copper-binding site variants with altered oxygen affinity

  • Engineering of disulfide bond patterns for enhanced stability

  • Modification of deimination/citrullination sites to control immune properties

  • Development of protease-resistant variants for extended biological half-life

Research has demonstrated that glycosylation sites at specific positions are crucial for hemocyanin's immunological functions . Similarly, the identification of hemocyanin subunit B as a deiminated protein suggests opportunities for engineering these modification sites to modulate functionality . These insights provide a foundation for rational design of enhanced hemocyanin variants for specific research and potential therapeutic applications.

What interdisciplinary approaches could reveal new applications for Cancer pagurus hemocyanin subunit B in biomedical research?

Interdisciplinary approaches can uncover novel applications for Cancer pagurus hemocyanin subunit B in biomedical research:

Immunology × Nanoengineering:

  • Development of hemocyanin-based nanocarriers for vaccine delivery

  • Engineering of hemocyanin nanoparticles with controlled immunostimulatory properties

  • Creation of multifunctional diagnostic platforms combining hemocyanin's binding and recognition properties

  • Design of biomimetic materials inspired by hemocyanin's structure-function relationships

Marine Biotechnology × Synthetic Biology:

  • Identification of bioactive peptides derived from hemocyanin sequences

  • Development of semi-synthetic hemocyanin variants with enhanced stability

  • Creation of artificial oxygen carriers based on hemocyanin architecture

  • Engineering of expression systems optimized for complex marine proteins

Structural Biology × Computational Modeling:

  • Prediction of functional epitopes for targeted engineering

  • Designing hemocyanin variants with tailored binding properties

  • Development of algorithms to predict immunomodulatory activity based on sequence

  • Virtual screening for molecules that modulate hemocyanin function

Glycobiology × Systems Immunology:

  • Analysis of glycan-dependent immune pathway activation

  • Investigation of glycosylation effects on cellular uptake mechanisms

  • Correlation of glycan patterns with specific immune cell targeting

  • Development of glycan-optimized hemocyanin for specific immune applications

Research has demonstrated that hemocyanin has diverse immunological functions, with specific glycosylation patterns being crucial for bacterial agglutination and antibacterial activities . Additionally, the identification of hemocyanin subunit B as a deiminated protein suggests potential roles in pathobiological processes, including extracellular trap formation and immune modulation . These findings indicate rich potential for interdisciplinary research to develop novel biomedical applications leveraging hemocyanin's unique properties.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.